Nanotechnology in life sciences: navigating the commercial development phase

Introduction

Featuring three expert speakers this event will explore some of the issues and opportunities surrounding the commercial development of nanotechnology in life sciences. Come along to hear a commercial perspective on bringing innovation into the mainstream, to think about some of the issues at the interface of research, industry and practice and to look ahead to emerging opportunities in the innovative field of nanotechnology in the UK.

Who should attend?

• Anyone working in nanotechnology research and business
• Practitioners interested in some of the nanotechnology developments set to impact healthcare and medicine
• Individuals and organisations interested in networking and sharing knowledge in this area

Registration

To register your place, please contact Joanna Westerman joanna@think-m.co.uk and 0191 2111957

Agenda

12.30: Registration

12.50-12.55: Welcome, Kenny Lang, CELS

12.55-13.35: Moving technology into everyday use, Elaine Warburton, CEO, Quantum DX

The Quantum DX team has many years of experience in bringing medical innovation into mainstream medicine and are currently marketing two new hand held devices for diagnostics and DNA sequencing, the latter being developed in Newcastle. Elaine Warburton (Quantum DX) will discuss how science in the lab becomes technology in practice drawing on her vast experience in biotech and healthcare management to share insight from a commercial perspective.

13.35-14:15: Overcoming hurdles on the route to commercialisation, Richard Moore, Nanomedicine and Lifesciences Manager, Insitute of Nanotechnology

Richard’s work involves facilitating a platform for sharing information between industry and medical practice. He will discuss some of the challenges inherent in the commercialisation of nanotechnology in life sciences with a specific focus on clinician-researcher-industry interaction. What are the obstacles and what tools can be employed to overcome them?

14:15 – 14:45: Break and networking

14:45-15:30: Emerging opportunities for nano in life sciences: a future view, Dr Mike Fisher, Theme Manager – Bionano & NanoMedicine, NanoKTN

There are a growing number of specialist nanotechnology companies in the UK and over 1,500 research scientists focusing on the development of nanotechnology. It will continue to have a major impact in the development of biotechnology, pharmaceuticals, healthcare and medicine (UKTI). Dr Mike Fisher will discuss some of the main opportunities for the advancement of nanotechnology in the mainstream, highlighting where potential lies for researchers and industry to meet unmet needs and continue to contribute to the growth of this exciting sector.

15:30 -16:00: Networking and close

Registration

To register your place, please contact Joanna Westerman joanna@think-m.co.uk and 0191 2111957